68 results on '"Mikhailidis, Dimitri P."'
Search Results
2. An international, multispecialty, expert-based Delphi Consensus document on controversial issues in the management of patients with asymptomatic and symptomatic carotid stenosis
3. Carotid Plaque-RADS: A Novel Stroke Risk Classification System
4. Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation
5. Carotid Artery Pathology in Inflammatory Diseases
6. Optimal Management of Asymptomatic Carotid Stenosis in 2021: The Jury is Still Out. An International, Multispecialty, Expert Review and Position Statement
7. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
8. Homocysteine and diabetes: Role in macrovascular and microvascular complications
9. Commentary: From mice to men: In search for dietary interventions to form the background on which pharmacotherapy for non-alcoholic fatty liver disease should be based
10. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
11. The Role of Nutraceuticals in Statin Intolerant Patients
12. Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials
13. Statin Intolerance: Some Practical Hints
14. Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis
15. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
16. Lipid-modifying effects of nutraceuticals: An evidence-based approach
17. Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patients
18. Non-alcoholic fatty liver disease and dyslipidemia: An update
19. Does bilirubin protect against developing diabetes mellitus?
20. Abdominal aortic aneurysms and diabetes mellitus
21. A possible relationship between renal impairment and complications development in type 2 diabetes mellitus: a prospective, observational study in Italy
22. Effects of oral hypoglycemic agents on platelet function
23. High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus
24. Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials
25. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness
26. Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients
27. Angiotensin II Increases Corpus Cavernosal Contractility and Oxidative Stress in Partial Bladder Outlet Obstructed Rabbits: Relevance to Erectile Dysfunction
28. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
29. Correlation of the severity of diabetic retinopathy and the heart muscle perfusion in patients with type 2 diabetes
30. Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated Relaxation
31. Incidence and predictors of delirium after cardiac surgery: Results from The IPDACS Study
32. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes
33. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!
34. Epicardial, peripancreatic and other “orthotopic” excessive fat deposition in south Asians and Europeans: Are differences clinically relevant?
35. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
36. Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence
37. Targeting vascular risk in patients with metabolic syndrome but without diabetes
38. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study
39. Statin use and renal function after aortic aneurysm repair procedures
40. Treating dyslipidaemia in non-insulin-dependent diabetes mellitus — a special reference to statins
41. More Good News on Statins and COVID-19
42. Differential Alterations of Spontaneous and Stimulated 45Ca 2+ Uptake by Platelets from Patients with Type I and Type II Diabetes Mellitus
43. Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A “non-invasive alternative” to liver biopsy?
44. Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
45. Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors: Shaping the future after the further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk (FOURIER) trial
46. Response letter: Statins and non-alcoholic steatohepatitis
47. Statins and non-alcoholic steatohepatitis
48. COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
49. IMPACT OF L-CARNITINE ON PLASMA LIPOPROTEIN(A) CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
50. High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes. Implications for everyday practice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.